Olympus   Report issue

For profit Phase 2
Founded: Tokyo Japan (1919)
Status: No NME R&D (1919)

Organization Overview

First Clinical Trial
2015
NCT03690323
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Olympus

Indications

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 8